James Li is the founder of JW Therapeutics. JW Therapeutics has raised $196M in total funding. Latest round: IPO. Based in Shanghai, China.
James Li is the co-founder and former CEO of JW Therapeutics, a Shanghai-based cell therapy company specializing in CAR-T immunotherapies. He led the company through its IPO on the Hong Kong Stock Exchange in November 2020. Currently, he is a Venture Partner at Frazier LS.
Full founder directory · Investor directory · Company funding database · Fundraising library